Industry News

The University of California, Berkeley is planning to construct the Bakar ClimatEnginuity Hub as part of a new downtown innovation zone. Designed by Gensler, the five-story, 145,000-sf facility will provide wet and dry laboratories, collaboration spaces, conference rooms, and offices. The robust structure will also include flexible scale-up suites for the development of renewable energy solutions, carbon-capture technologies, and greener building materials and agricultural practices. 

Children's Hospital of Philadelphia is constructing the $480 million Morgan Center for Research & Innovation on its Schuylkill River waterfront campus. Situated next to the existing Roberts Center for Pediatric Research, the 350,000-sf tower will provide state-of-the-art labs and core facilities where investigators and clinicians from different disciplines can engage in collaborative discovery.

Washington State University Vancouver dedicated the $63.8 million Life Sciences Building in June of 2024. Designed by SRG + CannonDesign, the 60,000-sf facility collocates the university’s basic, translational, applied, and clinical health programs in a single integrated location. The three-story structure provides faculty research suites, classrooms and teaching labs for biology and chemistry, and specialized learning venues for courses in nursing, psychology, neuroscience, medicine, and molecular biology.

The University of Massachusetts Amherst is constructing the Sustainable Engineering Laboratories, a national hub for clean energy innovation. Featuring flexible, multimodal learning venues, the $125 million facility was designed by Payette to provide technology-rich environments for immersive teaching and research programs. The vibrant structure will house the Energy Transition Institute, the Wind Energy Center, the UMass Transportation Center, and labs for autonomous vehicle technologies, energy storage, and ocean energy systems.

WACKER opened the mRNA Competence Center in June of 2024 in Halle an der Saale, Germany. Representing an investment of over €100 million, the next-generation facility enables the large-scale production of active ingredients based on messenger ribonucleic acid (mRNA). The building spans a total floor area of 79,653 sf and accommodates four new lines supported by advanced infrastructure, including 17,222 sf of glass-enclosed cleanroom space for bioprocessing under controlled conditions.